arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Oruka Therapeutics, Inc.

ORKA

$89.93 ▼ -4.65 (-4.92%) at close

23 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

Oruka Therapeutics, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -20.4% ↘

FCF / Share None

Trailing P/E —

Price / Book 9.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

23-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-105.43M

↓ -25.9% —

FCF / Share Free cash flow per share

$-3.46

↓ -893.7% —

Health Breakdown

Returns ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗
EPS Growth YoY (%)	—	-945.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	46.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	50.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-25.9% Weak ↑ Weak Improving Year-over-year change in net income	-1468.2% Weak ↓ Weak Declining Year-over-year change in net income	46.2% Excellent ↑ Excellent Improving Year-over-year change in net income	48.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-98.4% Weak ↓ Weak Declining Year-over-year change in net income	-77.6% Weak ↓ Weak Declining Year-over-year change in net income	30.9% Excellent ↑ Excellent Improving Year-over-year change in net income	57.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-12.4% Weak ↓ Weak Declining Year-over-year change in net income	-43.7% Weak ↓ Weak Declining Year-over-year change in net income	-18.1% Weak ↑ Weak Improving Year-over-year change in net income	87.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-10.2% Weak ↑ Weak Improving Year-over-year change in net income	-1167.6% Weak ↓ Weak Declining Year-over-year change in net income	36.3% Excellent ↑ Excellent Improving Year-over-year change in net income	7.9% Fair ↑ Fair Improving Year-over-year change in net income	53.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-38.9% Weak ↑ Weak Improving Year-over-year change in net income	-167.0% Weak ↑ Weak Improving Year-over-year change in net income	-259.2% Weak → Weak Stable Year-over-year change in net income	-185.5% Weak Weak Year-over-year change in net income	-340.5% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	—	-893.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	54.1% Excellent Excellent Year-over-year change in free cash flow	44.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	72.8% Excellent Excellent Year-over-year change in free cash flow	-971.2% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	1.40x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.46x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.30x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗
Return on Invested Capital (%)	-20.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-74.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-134.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-181.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-74.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-51.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-537.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2694.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-101.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-107.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—
Return on Capital (%) (%)	-25.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-68.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-118.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-151.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-67.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-60.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-620.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3086.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-113.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-112.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-22.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-249%)	-21.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-246%)	-14.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-23.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-37.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-352%)	-20.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-72.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-580%)	-131.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-977%)	-180.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1300%)	-74.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-594%)	-30.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-300%)	-65.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-538%)	—	—	-93.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-724%)	-124.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-929%)	-123.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-922%)	50.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+239%)	71.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+374%)	91.2% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+508%)	215.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1335%)	82.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+450%)	100.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+572%)

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗
Interest Coverage (x)	—	—	—	—	—	-1085.11x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-830.57x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1014.75x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3118.67x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	—	-2863.75x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3231.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-237.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-224.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1472.20x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1146.88x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$-46.94M	$-61.58M	$-37.43M	$-42.45M	$-53.36M	$-49.07M	$-8.36M	$-6.61M	$-8.70M	$-7.40M	$-38.80M	$-15.35M	$-16.76M	$-2.92M	$-5.94M	$-7.03M	$-7.76M	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗
Revenue per Share (USD)	—	—	$0.00	$0.00	—	—	—	—	—	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	—	$-3.87	$-0.37	$-0.69	$-1.39	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	$-3.46	$-0.35	$-0.76	$-1.35	—	—	—	—	—	—	—	$-84.76	$-311.91	$-29.12	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$9.69	$10.21	$2.55	$2.89	$3.54	$4.87	$4.77	$0.43	$0.87	$2.44	$4.21	$4.87	$6.95	$7.64	$19.74	$32.09	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$9.69	$10.21	$2.55	$2.89	$3.54	$4.87	$4.77	$0.43	$0.87	$2.44	$4.21	$4.87	$6.95	$7.64	$19.74	$32.09	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	—	16.79M	14.42M	14.41M	13.90M	—	—	—	—	—	—	2.93M	1.23M	318,361	239,643	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗
Working Capital (USD)	$328.48M	$363.83M	$36.95M	$41.57M	$50.92M	$46.47M	$7.55M	$5.98M	$10.23M	$19.05M	$37.41M	$14.10M	$15.42M	$2.74M	$5.46M	$5.97M	—	—	—	—	—	—	—
Total Equity (USD)	$471.93M	$382.22M	$37.02M	$41.67M	$51.04M	$46.52M	$7.61M	$6.03M	$10.28M	$22.19M	$38.07M	$14.74M	$15.58M	$2.91M	$5.73M	$6.77M	$7.41M	$-38.18M	$-19.69M	$-5.74M	$-678.00K	$-619.00K	$-115.00K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	—	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$83.00K	$27.00K	—	—	—	—	—	—	—	—	—	—	$1.80M	$43.00K	$602.00K	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-105.43M	$-83.72M	$-5.34M	$-9.93M	$-19.32M	$-9.74M	$-5.48M	$-7.93M	$-18.49M	$-16.44M	$-11.45M	$-9.69M	$-74.93M	$-67.99M	$-5.36M	$-8.42M	$-9.14M	$-19.43M	$-13.99M	$-5.24M	$-1.46M	$-511.00K	$-116.00K
Operating Cash Flow (USD)	$-88.21M	$-57.84M	$-5.01M	$-10.91M	$-18.76M	$-7.72M	$-4.80M	$-8.24M	$-17.47M	—	—	—	$-102.71M	$-97.42M	$-6.96M	$-8.32M	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 23 years · 88 quarters

Oruka Therapeutics, Inc.

Analytical Summary

23-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare ORKA with peers